ONTOLOGY REPORT - ANNOTATIONS
Term: rolipram
Accession: CHEBI:104872
browse the term
Definition: Pyrrolidin-2-one bearing a 3-(cyclopentyloxy)-4-methoxyphenyl substituent at the 4-position. It is a type IV-specific phosphodiesterase (PDE4) inhibitor.
Synonyms: exact_synonym: 4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one
related_synonym: 4-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-pyrrolidinone; C16H21NO3; COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1; InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18); InChIKey=HJORMJIFDVBMOB-UHFFFAOYSA-N; ZK 62711; rolipramum
alt_id: CHEBI:32104
xref_casrn: 61413-54-5
xref: Beilstein:1588548 "Beilstein Registry Number"; ChEMBL:104872 "ChEMBL COMPOUND"; ChemIDplus:61413-54-5 "CAS Registry Number"; CiteXplore:11163637 "PubMed citation"; CiteXplore:11239354 "PubMed citation"; CiteXplore:11408555 "PubMed citation"; CiteXplore:11555183 "PubMed citation"; CiteXplore:11737051 "PubMed citation"; CiteXplore:11739553 "PubMed citation"; CiteXplore:11959789 "PubMed citation"; CiteXplore:11978843 "PubMed citation"; CiteXplore:11992650 "PubMed citation"; CiteXplore:12003795 "PubMed citation"; CiteXplore:12065724 "PubMed citation"; CiteXplore:12191588 "PubMed citation"; CiteXplore:12447004 "PubMed citation"; CiteXplore:12508846 "PubMed citation"; CiteXplore:15114341 "PubMed citation"; CiteXplore:15277469 "PubMed citation"; CiteXplore:15374348 "PubMed citation"; CiteXplore:15646801 "PubMed citation"; CiteXplore:15744818 "PubMed citation"; CiteXplore:15790951 "PubMed citation"; CiteXplore:15839805 "PubMed citation"; CiteXplore:15986861 "PubMed citation"; CiteXplore:16010295 "PubMed citation"; CiteXplore:16022866 "PubMed citation"; CiteXplore:16077397 "PubMed citation"; CiteXplore:16129118 "PubMed citation"; CiteXplore:16190900 "PubMed citation"; CiteXplore:16242629 "PubMed citation"; CiteXplore:16250839 "PubMed citation"; CiteXplore:16253125 "PubMed citation"; CiteXplore:16254133 "PubMed citation"; CiteXplore:16442096 "PubMed citation"; CiteXplore:16455619 "PubMed citation"; CiteXplore:16962789 "PubMed citation"; CiteXplore:16968783 "PubMed citation"; CiteXplore:17081698 "PubMed citation"; CiteXplore:17097801 "PubMed citation"; CiteXplore:17390056 "PubMed citation"; CiteXplore:17489366 "PubMed citation"; CiteXplore:18311187 "PubMed citation"; CiteXplore:18347080 "PubMed citation"; CiteXplore:18424161 "PubMed citation"; CiteXplore:18437099 "PubMed citation"; CiteXplore:18554698 "PubMed citation"; CiteXplore:19554392 "PubMed citation"; CiteXplore:19569465 "PubMed citation"; DrugBank:DB01954 "DrugBank"; KEGG DRUG:D01783 "KEGG DRUG"
xref_mesh: MESH:D020889
xref: Patent:US4193926 "Patent"; Patent:US6337325 "Patent"; Patent:WO2011143607 "Patent"; Reaxys:1588548 "Reaxys Registry Number"; Wikipedia:Rolipram "Wikipedia"
rolipram
G
Adcyap1
adenylate cyclase activating polypeptide 1
multiple interactions
ISO
RGD:6480464
CTD
G
Areg
amphiregulin
increases expression
ISO
14
18,466,313
18,475,571
RGD:6480464
CTD
G
Bdnf
brain-derived neurotrophic factor
multiple interactions
EXP
RGD:6480464
CTD
G
Bdnf
brain-derived neurotrophic factor
increases expression
EXP
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
multiple interactions
EXP
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccl3
chemokine (C-C motif) ligand 3
multiple interactions
ISO
10
71,744,559
71,746,109
RGD:6480464
CTD
G
Cftr
cystic fibrosis transmembrane conductance regulator
multiple interactions
ISO
4
43,874,852
44,041,870
RGD:6480464
CTD
G
Cftr
cystic fibrosis transmembrane conductance regulator
decreases activity
ISO
4
43,874,852
44,041,870
RGD:6480464
CTD
G
Cftr
cystic fibrosis transmembrane conductance regulator
increases activity
ISO
4
43,874,852
44,041,870
RGD:6480464
CTD
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
9
63,170,785
63,234,727
RGD:6480464
CTD
G
Creb1
cAMP responsive element binding protein 1
increases expression
EXP
9
63,170,785
63,234,727
RGD:6480464
CTD
G
Edn1
endothelin 1
increases activity
EXP
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Il13
interleukin 13
decreases expression
ISO
10
39,093,512
39,096,069
RGD:6480464
CTD
G
Il13
interleukin 13
decreases secretion
ISO
10
39,093,512
39,096,069
RGD:6480464
CTD
G
Il18
interleukin 18
multiple interactions
ISO
8
53,936,584
53,943,228
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
multiple interactions
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
multiple interactions
EXP
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il1b
interleukin 1 beta
multiple interactions
ISO
3
116,964,422
116,970,867
RGD:6480464
CTD
G
Il4
interleukin 4
multiple interactions
ISO
10
39,074,582
39,080,134
RGD:6480464
CTD
G
Il6
interleukin 6
multiple interactions
ISO
4
456,799
461,376
RGD:6480464
CTD
G
Ltc4s
leukotriene C4 synthase
decreases secretion
ISO
10
35,786,877
35,788,838
RGD:6480464
CTD
G
Mpo
myeloperoxidase
multiple interactions
ISO
10
76,085,872
76,097,012
RGD:6480464
CTD
G
Mpo
myeloperoxidase
multiple interactions
EXP
10
76,085,872
76,097,012
RGD:6480464
CTD
G
Mpo
myeloperoxidase
multiple interactions
EXP
10
76,085,872
76,097,012
RGD:6480464
CTD
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
EXP
10
65,036,884
65,072,453
RGD:6480464
CTD
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
increases expression
EXP
17
11,494,463
11,811,654
RGD:6480464
CTD
G
Pde4a
phosphodiesterase 4A, cAMP-specific
multiple interactions
ISO
8
20,192,677
20,241,557
RGD:6480464
CTD
G
Pde4b
phosphodiesterase 4B, cAMP specific
multiple interactions
ISO
5
123,158,156
123,533,877
RGD:6480464
CTD
G
Pde4b
phosphodiesterase 4B, cAMP specific
multiple interactions
ISO
5
123,158,156
123,533,877
RGD:6480464
CTD
G
Sele
selectin E
multiple interactions
ISO
13
79,813,455
79,822,845
RGD:6480464
CTD
G
Spp1
secreted phosphoprotein 1
multiple interactions
EXP
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
decreases expression
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest